Brokerages predict that ICU Medical, Incorporated (NASDAQ:ICUI) will announce sales of $314.60 million for the current quarter, according to Zacks. Two analysts have made estimates for ICU Medical’s earnings. The lowest sales estimate is $312.50 million and the highest is $316.70 million. ICU Medical posted sales of $370.12 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 15%. The company is expected to issue its next quarterly earnings report after the market closes on Thursday, February 28th.
On average, analysts expect that ICU Medical will report full year sales of $1.32 billion for the current financial year, with estimates ranging from $1.31 billion to $1.32 billion. For the next financial year, analysts expect that the company will post sales of $1.33 billion, with estimates ranging from $1.32 billion to $1.33 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that cover ICU Medical.
Several equities analysts recently commented on the stock. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday. Zacks Investment Research downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Friday, January 4th. Finally, ValuEngine downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, November 6th.
In related news, Director Robert S. Swinney sold 1,500 shares of the company’s stock in a transaction dated Monday, January 28th. The shares were sold at an average price of $242.19, for a total transaction of $363,285.00. Following the transaction, the director now directly owns 19,540 shares in the company, valued at approximately $4,732,392.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 12.50% of the company’s stock.
Large investors have recently modified their holdings of the stock. Advisory Services Network LLC boosted its position in ICU Medical by 475.0% in the 4th quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 95 shares during the period. Amalgamated Bank boosted its position in ICU Medical by 59.6% in the 4th quarter. Amalgamated Bank now owns 3,660 shares of the medical instruments supplier’s stock valued at $840,000 after buying an additional 1,367 shares during the period. Legal & General Group Plc boosted its position in ICU Medical by 5.2% in the 4th quarter. Legal & General Group Plc now owns 19,449 shares of the medical instruments supplier’s stock valued at $4,466,000 after buying an additional 970 shares during the period. Smith Moore & CO. purchased a new stake in ICU Medical in the 4th quarter valued at about $254,000. Finally, Thrivent Financial for Lutherans boosted its position in ICU Medical by 6.0% in the 4th quarter. Thrivent Financial for Lutherans now owns 4,204 shares of the medical instruments supplier’s stock valued at $965,000 after buying an additional 239 shares during the period. Institutional investors own 80.28% of the company’s stock.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Read More: How Do Tariffs Affect Trade Balances?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.